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Objective: Nonprescription or over-the-counter (OTC) medications play a crucial role in a
patient’s ability to make choices to manage his or her own health care. Often these nonprescription choices are unknown to health care practitioners and thus are often not included as
part of patients’ health records. The exclusion of these therapies can pose risks to patient
safety. There is a signiﬁcant need to address the capture of OTC medication use in both the
physician and pharmacy electronic health records (EHRs) and during the practitionerepatient
medication history and reconciliation process.
Data sources: On October 26, 2016, the National Association of Chain Drug Stores Foundation
hosted a forum for a select group of health care industry professionals to work on a series of
recommendations to improve the documentation of OTC medication use by patients. This
diverse group of more than a dozen stakeholders included community pharmacy leaders from
multiple chain pharmacies, pharmacy system vendors, e-prescribing vendors, health information technology experts, and multiple industry representatives, including individuals from
the public sector. This commentary is a summary of the insights and suggestions where the
group was in general agreement.
Summary: Successful OTC medication EHR integration will require system-level buy-in across
multiple layers of the health care industry to improve patient safety. Forum participants
suggested incremental steps that could be taken by multiple stakeholders to lay the foundation for integration within an appropriate regulatory structure.
Conclusion: Based on the results of the stakeholder forum, an agreement formed around one
approach that the group supported as feasible: the creation of a consistent and uniform identiﬁcation method for OTC medications in cooperation with government regulatory authorities.
© 2018 The Author. Published by Elsevier Inc. on behalf of the American Pharmacists
Association®. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).

The purpose of this commentary is to provide a summary of
insights and suggestions by key community pharmacy
industry stakeholders (Table 1) who were asked to evaluate
the technological capability and opportunities to incorporate
over-the-counter (OTC) medications into comprehensive
electronic health records (EHRs).
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Goals of the forum
The stated goals of the forum were: (1) to provide an
environmental assessment of opportunities where OTC
medication information can be collected beginning with point
of sale; (2) to explain the role of technology in instances where
OTC medications are documented or omitted in the normal
process of care, including at the pharmacy; (3) to discuss the
feasibility of OTC medications being included in the EHR
through interoperability between physician and pharmacy
record systems; and (4) to provide system-level recommendations to begin collaboratively incorporating OTC medications into EHRs.
For the purposes of this commentary, EHRs, as deﬁned by
the Centers for Medicare and Medicaid Services, are an
electronic version of a patient’s medical history that are
maintained by the provider over time and can include all the
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Key Points
Background:
 The purpose of this commentary is to provide a
summary of insights and suggestions by key community pharmacy industry stakeholders who were
asked to evaluate the technological capability and
opportunities to incorporate over-the-counter (OTC)
medications into comprehensive electronic health
records (EHRs).
Findings:
 There were 3 key points of agreement that shaped
the recommendations:
 General Agreement, Point 1: Effective documentation systems for OTC medications in EHRs may help
to provide patients and providers with the necessary
information to increase appropriate OTC use.
 General Agreement, Point 2: System-level buy-in
across multiple layers of the health care industry will
be required for successful OTC-EHR integration.
 General Agreement, Point 3: Incremental steps by
multiple stakeholders should be taken to lay the
foundation for OTC-EHR integration, provided it is
within an appropriate regulatory structure.

key administrative clinical data relevant to that person’s care
under a particular provider.1 Currently, community pharmacy
dispensing systems often do not collect OTC information, nor
do they communicate with physician ofﬁce EHRs.
Overview of nonprescription drug use
OTC medications play a crucial role in our nation’s health
care system by increasing access to effective medications and
empowering individuals to make health care choices for
themselves and their families. A recent consumer survey
found that 89% of consumers value OTC medications as part of
their health care and 81% of U.S. adults use OTC medicines as a
ﬁrst response to minor ailments.2 Furthermore, in a survey of
more than 500 health care practitioners, 89% of pediatricians
surveyed either recommended or had no reservations recommending OTC medications to their patients.3
Enhanced access to these medications empowers patients
to take an active role in their health and improves the health
care system overall. Taken correctly, OTC medications are safe,
affordable, and effective.
Patient safety and gaps in care
Although OTC medications improve the health of millions of
patients, risks due to inappropriate use can pose a substantial
risk to patient safety, including complications from drugedrug
interactions, accidental drug duplication, and unforeseen
drugedisease complications. The high prevalence of OTC
medication use means that these risks are not insigniﬁcant. For
example, in a survey of patients with heart failure, 88% reported
2

OTC medication use.4 The OTC medications used included
nonsteroidal anti-inﬂammatory drugs (NSAIDs), proton pump
inhibitors, antacids, and decongestants. NSAIDs, in particular,
could have serious implications in patients with heart failure.
The risk of OTC medication interactions owing to lack of
documentation has been conﬁrmed in multiple studies. In a
retrospective analysis of electronic patient health records in
Dutch community pharmacies, 44% did not accurately include
OTC medications.5 In another study, 60% of surveyed patients
were unaware of the risks associated with NSAID use, and 30%
thought that OTC medicines were safer because they were
available without a prescription.6 Lastly, in a retrospective EHR
chart review at a primary care center, pharmacists identiﬁed
that nearly 75% of EHR entries had at least 1 discrepancy, and
the omission of OTC medication use was the most common.7
Improved OTC documentation could reduce discrepancies to
affect patient care positively.
How prescription documentation differs from OTC
There are major differences in the way that EHRs document
prescription medications compared with OTC medications.
Currently, it is easier to capture prescription medication use
in EHRs because of electronic prescribing and the extensive insurance payment systems that exist to document and pay for
prescription medications. Pharmacy beneﬁt managers, eprescribing systems, and pharmacy dispensing software must
tightly function to adequately complete the prescription drug
dispensing process. By contrast, most OTC medication transactions occur at a retail location, often outside the pharmacy,
where a consumer does not use his or her health insurance but
pays out of pocket. Few, if any, systems are in place to capture this
OTC transaction information. Thus, OTC medication safety alerts
and other prescribing information are not as readily accessible to
prescribers and patients as their prescribed counterparts.
Because of these current challenges in documenting OTC
medications, most of them are simply input into EHRs by
providers as free-form text entries when conducting a medication history or medication reconciliation with the patient.
This type of documentation can inhibit the accurate and efﬁcient communication of OTC medication use across EHRs in
the future, leading to potential exclusion from the alert
screening process. Furthermore, lack of health information
technology interoperability between disparate data systems
limits exchange of data. EHR interoperability is a subject
beyond the scope of the forum discussion. However, efforts led
by the Ofﬁce of the National Coordinator (ONC) will play a key
role in any future documentation and communication of OTC
medications, including the Pharmacist eCare Plan. Speciﬁc
features related to the documentation of OTC medications
within the IT construct were considered to help facilitate inclusion and implementation of health information technology
interoperability efforts in the future.
Existing identiﬁers: NDCs, UPCs, and SKUs
Forum stakeholders noted that OTC medications each
contain a National Drug Code (NDC), which is required for
registration with the U.S. Food and Drug Administration. Participants suggested that the use of NDCs might offer the best
short-term solution for the identiﬁcation of speciﬁc OTC
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Table 1
Stakeholder information
Participants
 Jon Arends, PharmD, Walgreens Co., Senior Manager, Director,
Electronic Prescribing
 Leslie Bloom, MS, Johnson & Johnson Consumer Inc., Director,
Scientiﬁc Education and Patient Advocacy
 Rebecca Chater, BSPharm, MPH, FAPhA, Ateb, Executive Healthcare
Strategist
 Tammy Devine, MBA, QS/1, President
 Ajit Dhavle, PharmD, MBA, Surescripts, VP of Clinical Quality
 Justin Heiser, PharmD, Thrifty White Pharmacy, SVP, Pharmacy
Operations
 Jill Helm, PharmD, AllScripts Healthcare Solutions, Inc., VP, Business
Development for Payer Life Sciences
 Jeff Key, MCS, PioneerRx, President
 Tammy Royer, BSPharm, Rite Aid Corporation, SVP of Pharmacy
Operations
 Dan Snodgrass, BSPharm, The Procter & Gamble Company, Senior
Manager Strategy/Planning
 Rachelle (Shelly) Spiro, BSPharm, FASCP, Pharmacy HIT
Collaborative, Executive Director
 Stephen Vaudry, MBA, CVS Health, Director, Patient Safety
Acknowledgment of Contribution to the Stakeholder Forum
 Trygve Anderson, Elsevier, Clinical Executive
 Thomas R. Bizzaro, First Databank Inc., VP, Health Policy and
Industry Relations
 Kim C. Coley, PharmD, FCCP, University of Pittsburgh School of
Pharmacy, Professor of Pharmacy and Therapeutics
 Melissa Somma McGivney, PharmD, FCCP, FAPhA, University of
Pittsburgh School of Pharmacy, Associate Dean for Community
Partnerships, Associate Professor
 Patricia Milazzo, Walters Kluwer, Senior Director, Content

medication products because of the prevalence of NDCs within
the existing regulatory structure.
Stakeholders noted that alternative solutions for identiﬁcation of OTC medications outside the NDCs are currently
being created in the private sector but shared that a lack of
consistency in labeling and drug information for OTC medications poses a signiﬁcant impediment to their widespread
EHR adoption.
For example, unique product codes (UPCs) have a similar
number, which is assigned by the product manufacturer. In
some cases, the UPC is the NDC code with a 1 or 0 attached.
However, UPCs are not required to have the same component
consistency as an NDC code.
OTC medication products also contain an identiﬁcation
code at each business for price scanning and inventory purposes, commonly known as a stock keeping unit (SKU).
However, SKU purchase history and data are not currently tied
to any clinical data system, even within pharmacies.
Other technology-facilitated programs considered by
Forum participants:
 Loyalty Programs: Loyalty programs are comonly used by
retailers in marketing to offer deals and targeted advertising. A customer’s shopping history could provide retailspeciﬁc data on OTC purchases. However, stakeholders
noted that businesses might not be inclined to adapt their
existing programs to embrace the inclusion of EHR integration. In addition, many loyalty programs are household-,
not individual-based, making them less than ideal for
identifying patient-speciﬁc OTC medication use.
 Health Savings Accounts: Some employer-sponsored insurance plans offer federal Health Savings Accounts,

allowing employees to use before tax dollars to pay for
health care products not reimbursed by insurance,
including OTC medications. This could serve some purposes
of data collection. However, this option would be limited
because Health Savings Accounts are only available to those
covered by employer-sponsored health insurance.
 Pharmacy Dispensing Software: Commercially available
pharmacy dispensing software can capture and record OTC
medication use. However, most information is limited to data
reported by the patient verbally during potential consultations or discussions between patient and pharmacistda
mere fraction of overall OTC use.

Challenges
Forum stakeholders agreed that for effective and accurate
documentation within an EHR, the following overarching
challenges must be addressed:
 Many Retailers: One of the top challenges was the availability of OTC medications through a vast array of retail
outlets. In addition to pharmacies, supermarkets, wholesale clubs, and online merchants, OTC medications are
available in places such as gas stations, convenience stores,
hotel gift shops, airport newspaper stands, and many
others. There are an estimated 750,000 total retail locations
in the United States.8 While convenient, this poses a major
challenge to EHR integration.
 Purchaser versus End User: Purchasers are not necessarily
end users. Purchase history of OTC drug products alone
does not necessarily describe individual OTC medication
use. In many cases, consumers can purchase medications
for someone within their family or can share their medicines with another individual not in their home, such as a
neighbor, friend, or co-worker.
 Privacy: Effectively capturing OTC medication data with the
consumer’s active consent may require the health care
system to meet privacy expectations like those in place for
prescription medications. Stakeholders reinforced the
importance of consumer trust to adequately address privacy concerns.
While these challenges are mostly logistical, the stakeholders of the conference offered a ﬁrst-step consideration to
begin addressing a few speciﬁc disease states, such as diabetes
or cardiovascular disease where risks to patient safety are
greater than for others. Selectively targeting speciﬁc medical
conditions along with OTC medicines that contain warnings
related to use in individuals with that same medical condition
was considered a reasonable ﬁrst step.
Patienteprovider interaction
The current primary documentation of OTC medication use
in the EHR still occurs as part of a one-on-one interaction with
a health care provider. Often, when patients are asked about
their medication use, they will defer to listing their prescription medications and possibly daily OTC medications. Yet,
consumers use OTC medications far more frequently than they
interact with their physicians. On average, consumers make 26
3
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Table 2
Logic model: Progression concept for prescription and over-the-counter medical record integration
Strategy and activities

Short-term outcomes

Intermediate outcomes

Long-term outcomes

Selectively targeting speciﬁc medical
conditions along with OTC medicines that
contain warnings related to use of the OTC
medicine in individuals with that same
medical condition. An example of this
would be CV disease and NSAIDs that
have CV-related warnings.
Engage manufacturers and FDA regarding the
creation of a uniform identiﬁcation system.

Increased industry awareness
of Rx/OTC EHR integration
approach and strategy for
achieving it

Increased number of private
industry collaborators

Increased patient safety/
decreased incidence of
preventable adverse drug
reactions

Create an industry and regulatory
collaboration to enhance reporting of OTC
medication-speciﬁc information.

Increased publiceprivate
collaboration

Increased opportunities to
engage patients and providers
through technology
Increased testing and use of
patient-driven innovations for
EHR integration (including the
Pharmacist eCare Plan)

Anticipate patient-driven technologies by
building adaptability into the data collection
design.
Abbreviations used: OCT, over-the-counter; CV, cardiovascular; NSAID, nonsteroidal anti-inﬂammatory drug; Rx, prescription; EHR, electronic health records;
FDA, U.S. Food and Drug Administration.

trips to purchase OTC medications over a 12-month period
compared with 3 visits to their physician over the same time
span.8 This fact alone lends perspective to the challenge of OTC
integration into EHRs.
Studies have shown that one method of improving medication record accuracy is to provide patients online access to
their data before medical visits.9 However, stakeholders
conﬁrmed that inherent barriers exist when applying that
same approach to reporting OTC medication use.

could incentivize providers to improve collection of OTC utilization during patient encounters.
Conclusion
The integration of OTC medications into patients’ EHRs is a
complex issue that has the potential to affect patient care
positively and to improve outcomes. Table 2 represents
stakeholders’ recommendations to work toward OTC medication EHR integration:

Patient-driven solutions
Software systems known as applications or apps can collect,
document, and provide resources directly to a patient’s laptop
or mobile device, potentially enhancing patient understanding
and documentation of OTC medications. Current technology,
including scanning for QR codes or barcodes, could link to an
NDC and speciﬁc medication information for each OTC medication. However, the creation and widespread use of such
technology are in the early stages of development and
adoption.
Furthermore, stakeholders identiﬁed the need for patients
to be incentivized to report OTC medication use. To date, the
usefulness of patient-driven electronic personal health records
has been met with mixed results. One promising app was ultimately discontinued because of the inability to reach consumers effectively. Major contributing factors included lack of
patient education, promoting patient usefulness, and encouraging trust from the user.10
Increasing patient awareness and education was considered outside the scope of the Forum discussion, but stakeholders agreed that any efforts to create a consistent uniform
code for identiﬁcation should take these considerations into
account.

1. Create a consistent, uniform identiﬁcation method for OTC
medications.
 Target a narrow set of high-priority health conditions and
related OTC medications as a starting place for uniform
identiﬁcation.
 Enlist the participation of OTC manufacturers, the U.S.
Food and Drug Administration, and appropriate government entities regarding the creation and consistent
execution of a uniform identiﬁcation system.
 Create a publiceprivate collaboration to enhance
reporting of OTC medication speciﬁc information.
2. Anticipate the potential for future patient engagement
through patient-driven technologies, such as apps, by
building adaptability into data collection design.
A focus on standardized integration of OTC information for
new and changing products could potentially increase the
appropriate choice and use of OTC products for some individuals, allowing the basis by which they can be integrated
into pharmacists’ patient care process and team-based care.
Lastly, payers can create value for patients, providers, and
system vendors by aligning payments with developed quality
measures and incentivizing documentation of OTC medications in EHR systems.

Payer-driven solutions
Acknowledgments
One way that changes in health care provision can be
driven is by implementation of new, quality metrics. A performance measure around OTC documentation in the EHR
4
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